A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
NCT ID: NCT01182025
Last Updated: 2010-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
360 participants
INTERVENTIONAL
2010-06-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
NCT01175915
The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases
NCT04937101
A Study of KHK4827 in Subjects With Palmoplantar Pustulosis
NCT04061252
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917
Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema
NCT02601222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Western therapy
Western therapy
Symptomatic treatment: vitamin B, vitamin C, mouth care and skin care.
1. Adopting physical cooling therapy, including physical cooling paste or warm bathing, when patient's body temperature is lower than 38.5 degree Celsius;
2. Using Ibuprofen suspension when patient's temperature higher than 38.5 degree Celsius;
Xiyanping Injection
Xiyanping Injection
Dosage for child medication:
5-10mg/kg/d (0.2-0.4ml/kg/d) in 5% Glucose solution, IV, with speed of 20-30 drops per minute, each day; or as directed by doctor.
Xiyanping Injection with western medicine
Xiyanping Injection with western medicine
1. Symptomatic treatment using the same treatment methods in western therapy group;
2. Symptomatic treatment using the same treatment methods in Xiyanpin injection group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Western therapy
Symptomatic treatment: vitamin B, vitamin C, mouth care and skin care.
1. Adopting physical cooling therapy, including physical cooling paste or warm bathing, when patient's body temperature is lower than 38.5 degree Celsius;
2. Using Ibuprofen suspension when patient's temperature higher than 38.5 degree Celsius;
Xiyanping Injection
Dosage for child medication:
5-10mg/kg/d (0.2-0.4ml/kg/d) in 5% Glucose solution, IV, with speed of 20-30 drops per minute, each day; or as directed by doctor.
Xiyanping Injection with western medicine
1. Symptomatic treatment using the same treatment methods in western therapy group;
2. Symptomatic treatment using the same treatment methods in Xiyanpin injection group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Less than 48 hours of occurrence of fever and/or occurrence of tetter or herpes.
* Age of 1-14 years.
* Patients or their guardians agree to participate in this study and signed the informed consent form.
Exclusion Criteria
* With history of allergies on traditional Chinese medicine.
* Patients or their guardians suffering from Psychiatric diseases.
* Attending other clinical studies on HFMD after diagnosed.
1 Year
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing University of Chinese Medicine
OTHER
China Academy of Chinese Medical Sciences
OTHER
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The First Affiliated Hospital of Anhui College of Traditional Chinese Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guoliang Zhang
Role: PRINCIPAL_INVESTIGATOR
An'Hui Chinese Medical College Affiliated No.1 Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Guilin Medical College
Guilin, Guangxi, China
Liuzhou Worker's Hospital
Liuzhou, Guangxi, China
Liuzhou People's Hospital
Liuzhou, Guangxi, China
Shenzhen Maternity & Child Healthcare Hospital
Shenzhen, Guangzhou, China
Jiangxi Provincial Children's Hospital
Nanchang, Jiangxi, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200907001-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.